Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers

Completed · Phase 3

Conditions studied: Healthy Volunteers Eligible for Study; Drug Being Developed for Allergic Conjunctivitis

In brief

The purpose of this study is to evaluate the safety of R89674 0.25% ophthalmic solution in healthy normal volunteers

Key facts

Study ID

NCT00223951

Run by

Vistakon Pharmaceuticals

People needed

900

Starts

2005-09-01

Last updated by the study team

2015-02-20

Who can join

Age: 3 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• healthy normal volunteers age >=3 years with normal ocular health and a best-corrected logMAR score of 0.3 or better

You may not qualify if…

• intraocular surgery and/or ocular surgical intervention within last 3 months, refractive surgery within last 6 months, active ocular disorder other than refractive disorders, breastfeeding women, pregnant female < 18 years of age -

Where it is running

• Study site — Phoenix, Arizona, United States
• Study site — Bel Air, Maryland, United States
• Study site — North Andover, Massachusetts, United States
• Study site — Las Vegas, Nevada, United States
• Study site — Charlotte, North Carolina, United States
• Study site — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.